Mannkind Corporation

Form 483 issued October 3, 2024 · Marlborough, Massachusetts

Inspection
Sep 19 – Oct 3, 2024
Investigator
Sara M. Onyango
Observations
5
Pages
6
FEI number
3003154078

In short: On October 3, 2024, FDA issued a Form 483 with 5 observations to Mannkind Corporation in Marlborough, Massachusetts (FEI 3003154078) after an inspection that ran Sep 19 – Oct 3, 2024. The investigator was Sara M. Onyango. Most observations concern design controls and cAPA; the most-cited regulation is 21 CFR 820.30 (design controls).

At a glance

Design controls and capa account for 4 of 5 observations.

Design controls2
CAPA2
Production & process controls1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Sampling plans are not based…

  2. 02

    Procedures for design change have…

  3. 03

    Design validation did not ensure the device conforms to defined user…

  4. 04

    Procedures for corrective and preventive action have…

1 more observation

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Mannkind Corporation?

FDA listed 5 observations on this Form 483, mostly about design controls, cAPA and production & process controls. The most-cited regulation is 21 CFR 820.30 (design controls). The opening words of each observation are shown on this page.

Who inspected Mannkind Corporation?

Sara M. Onyango is named on this Form 483, for the inspection of Sep 19 – Oct 3, 2024. Each investigator has a profile showing what they cite most.

When was Mannkind Corporation inspected by FDA?

The inspection ran Sep 19 – Oct 3, 2024, and the Form 483 is dated October 3, 2024.

How do I get the full Form 483 for Mannkind Corporation?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free